Lance Alexander speaks with Dr Tan Ru San, Senior Consultant, Department of Cardiology, National Heart Centre Singapore (NHCS), about the critical weeks after a heart attack and why leaving hospital does not mean the danger has passed.

Why should LDL cholesterol be checked again within four to six weeks? How low should “bad” cholesterol go, and what happens if a patient is still not meeting the target?

They also discuss the risk of a second heart attack, the role of medication and lifestyle changes, and what patients should do if they experience side effects or have concerns about their treatment.

Lance Alexander speaks with Dr Tan Ru San, Senior Consultant, Department of Cardiology, National Heart Centre Singapore (NHCS), about the critical weeks after a heart attack and why leaving hospital does not mean the danger has passed.
Why should LDL cholesterol be checked again within four to six weeks? How low should &ldquo;bad&rdquo; cholesterol go, and what happens if a patient is still not meeting the target?
They also discuss the risk of a second heart attack, the role of medication and lifestyle changes, and what patients should do if they experience side effects or have concerns about their treatment.

Start your day on a positive note with Live Well with Michelle Martin.

The show explores wellbeing in all its dimensions — from self-awareness and personal growth to money, investing, and everyday lifestyle. Through thoughtful interviews and engaging conversations, Michelle speaks with experts and changemakers on living and ageing well, while helping you discover new ideas — from great books on READ and inspiring voices on INFLUENCE, to practical financial insights on MONEY AND ME.

In a fast-moving world that can often feel overwhelming, Live Well offers a refreshing counterpoint — with insights, ideas and stories that help you feel informed, empowered and ready to take on the day.

Start your day on a positive note with Live Well with Michelle Martin.
The show explores wellbeing in all its dimensions &mdash; from self-awareness and personal growth to money, investing, and everyday lifestyle. Through thoughtful interviews and engaging conversations, Michelle speaks with experts and changemakers on living and ageing well, while helping you discover new ideas &mdash; from great books on READ and inspiring voices on INFLUENCE, to practical financial insights on MONEY AND ME.
In a fast-moving world that can often feel overwhelming, Live Well offers a refreshing counterpoint &mdash; with insights, ideas and stories that help you feel informed, empowered and ready to take on the day.

Live Well with Michelle

MONEY FM 89.3 is Singapore’s first and only Business and Personal Finance station. MONEY FM is a 24-hour English talk format station featuring local and international business and financial news. We provide you with financial market and currency updates and insights from analysts, economists, policy makers, industry experts and business owners.

In the lighter hours, listen to discussions on social issues and features on topics that include health, education, arts and music.

MONEY FM 89.3 is Singapore&rsquo;s first and only Business and Personal Finance station. MONEY FM is a 24-hour English talk format station featuring local and international business and financial news. We provide you with financial market and currency updates and insights from analysts, economists, policy makers, industry experts and business owners.
In the lighter hours, listen to discussions on social issues and features on topics that include health, education, arts and music.

MONEY FM 89.3 is Singapore’s first and only Business and Personal Finance station.

MONEY FM 89.3

Start your day on a positive note with Live Well with Michelle Martin.

Live Well with Michelle (10am to 1pm)

On World Heart Day, we want to know, after a heart attack, what happens next?

Lance Alexander speaks with Cheng Chye Hsern, Head of Investment, Providend, about the US Federal Reserve’s latest interest rate hike and where rates could be heading next. With Singapore T-bill yields rising, should investors be parking more cash in T-bills, what are the risks, and what other options are worth considering? They also examine what higher interest rates mean for Singapore REITs and the three local banks - DBS, OCBC and UOB. Should investors rethink their holdings? Plus, why has gold come under pressure despite persistent inflation, and does it still deserve a place in investors’ portfolios?

Lance Alexander speaks with Cheng Chye Hsern, Head of Investment, Providend, about the US Federal Reserve&rsquo;s latest interest rate hike and where rates could be heading next. With Singapore T-bill yields rising, should investors be parking more cash in T-bills, what are the risks, and what other options are worth considering?&nbsp;They also examine what higher interest rates mean for Singapore REITs and the three local banks - DBS, OCBC and UOB. Should investors rethink their holdings?&nbsp;Plus, why has gold come under pressure despite persistent inflation, and does it still deserve a place in investors&rsquo; portfolios?

Money and Me: Rising interest rates - Should you buy T-Bills, REITs, Bank Stocks or Gold?

Is the recent market turbulence creating buying opportunities?

Michelle Martin looks at Bank of America’s call on Nvidia and other stocks it believes are now attractively priced, as bond-market warning signals loom over a new trading week.

Plus, the battle for the obesity-drug market intensifies as Novo Nordisk searches for its next growth chapter against Eli Lilly, while another pharma stock rockets on an injectables deal with the Wegovy maker.

In Up or Down, why has Microsoft climbed back to its highest close of 2026, why did the launch of the long-awaited Tesla Semi fail to excite investors, and what are insider buying and a bigger share-buyback programme telling us about Singapore-listed Nam Cheong and Seatrium?

And in the Last Word: Avengers: Endgame returns to cinemas - and seven years later, Earth's mightiest heroes are back on top at the box office.

Is the recent market turbulence creating buying opportunities?
Michelle Martin looks at Bank of America&rsquo;s call on Nvidia and other stocks it believes are now attractively priced, as bond-market warning signals loom over a new trading week.
Plus, the battle for the obesity-drug market intensifies as&nbsp;Novo Nordisk&nbsp;searches for its next growth chapter against&nbsp;Eli Lilly, while another pharma stock rockets on an injectables deal with the Wegovy maker.
In&nbsp;Up or Down, why has&nbsp;Microsoft&nbsp;climbed back to its highest close of 2026, why did the launch of the long-awaited&nbsp;Tesla Semi&nbsp;fail to excite investors, and what are insider buying and a bigger share-buyback programme telling us about Singapore-listed&nbsp;Nam Cheong and Seatrium?
And in the Last Word:&nbsp;Avengers: Endgame returns to cinemas - and seven years later, Earth's mightiest heroes are back on top at the box office.

Market View: Nvidia on Sale? Novo vs Lilly, Microsoft’s Comeback and Tesla’s Semi Problem

Singapore declared war on diabetes a decade ago, yet the condition still affects around one in eleven adults, while rising obesity adds to concerns about Type 2 diabetes.

Michelle Martin speaks with Dr Anuradha Negi, Senior Consultant Endocrinologist at the Aspen Diabetes & Endocrine Clinic, about what everyone should understand about Type 1 and Type 2 diabetes, who is most at risk, and the practical steps that can help prevent or better manage the condition.

They also examine the growing role of continuous glucose monitoring (CGM).

How much more can a sensor reveal compared with a finger-prick test? Who benefits most from having glucose readings throughout the day?

And with CGM currently subsidised in Singapore for eligible patients with Type 1 and certain rarer forms of diabetes, could some people with Type 2 diabetes benefit from wider access?

Plus, Dr Negi explains the limitations of CGM, when traditional glucose testing may still be necessary, and what good diabetes management looks like beyond medication.

Singapore declared war on diabetes a decade ago, yet the condition still affects around one in eleven adults, while rising obesity adds to concerns about Type 2 diabetes.
Michelle Martin speaks with Dr Anuradha Negi, Senior Consultant Endocrinologist at the Aspen Diabetes &amp; Endocrine Clinic, about what everyone should understand about Type 1 and Type 2 diabetes, who is most at risk, and the practical steps that can help prevent or better manage the condition.
They also examine the growing role of continuous glucose monitoring (CGM).
How much more can a sensor reveal compared with a finger-prick test? Who benefits most from having glucose readings throughout the day?
And with CGM currently subsidised in Singapore for eligible patients with Type 1 and certain rarer forms of diabetes, could some people with Type 2 diabetes benefit from wider access?
Plus, Dr Negi explains the limitations of CGM, when traditional glucose testing may still be necessary, and what good diabetes management looks like beyond medication.

On World Heart Day, we want to know, after a heart attack, what happens next?

In 2 playlist(s)

Live Well with Michelle (10am to 1pm)

Social links

Follow podcast

Recent clips